We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
WHX Labs Dubai 2026
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Varian Acquires IonSpec

By Biotechdaily staff writers
Posted on 10 Mar 2006
Varian, Inc. (Palo Alto, CA, USA) has acquired IonSpec Corp. (Lake Forest, CA, USA) for approximately U.S.$16 million.

Varian said the acquisitions of IonSpec's Fourier transform mass spectrometry (FTMS) technology represents a significant step toward expanding its information-rich detection (IRD) portfolio.

Varian expects the acquisition to increase its development of growing life science applications, specifically the study of proteins, nucleic acids, and drug metabolites. The initial cash purchase price includes paying down assumed debt and an opportunity for an additional payment if FTMS products reach specified financial targets over a three-year period.

FTMS instruments are used in laboratories worldwide to determine the function and structural characterization of proteins and other biomolecules in various biologic systems.




Related Links:
Varian
IonSpec

Gold Member
Respiratory Syncytial Virus Test
OSOMĀ® RSV Test
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Gold Member
Immunochromatographic Assay
CRYPTO Cassette

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
10 Mar 2006  |   BioResearch

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
10 Mar 2006  |   BioResearch

New Method Simplifies Preparation of Tumor Genomic DNA Libraries
10 Mar 2006  |   BioResearch